Abstract Cervical cancer is one of the most common gynecologic malignancies and poses a serious health problem worldwide. Identification and characterization of cervical cancer stem cells may facilitate the development of novel strategies for the treatment of advanced and metastatic cervical cancer. Breast cancer-resistance protein (Bcrp1)-positive cells were selected from a population of parent HeLa cells using flow cytometry. The invasion capacity of Bcrp1-positive and -negative cells was analyzed with a Boyden chamber invasion test. The tumorigenicity of these cells was determined by in vivo transplantation in non-obesity diabetes/severe combined immunodeficiency (NOD/SCID) mice. The Bcrp1-positive subpopulation accounted for about 7% of the parent HeLa cell population. The proliferative capacity of the Bcrp1-positive cells was greater than that of the Bcrp1-negative cells (P \ 0.05). In the invasion assay, the Bcrp1-positive cells demonstrated a greater invasive capacity through the artificial basement membrane than their Bcrp1-negative counterparts. Following transplantation of 10 4 cells, only the Bcrp1-positive cells formed tumors in NOD/SCID mice. When 10 5 or 10 6 cells were transplanted, the tumor incidence and the tumor mass were greater in the Bcrp1-positive groups than those in the Bcrp1-negative groups (P \ 0.05). The Bcrp1-positive subpopulation cervical cancer stem cells.
Introduction
Cervical cancer is one of the most common gynecological malignancies. With the introduction of cervical cytological scanning and improved early diagnosis, its morbidity and mortality have significantly decreased in the past four decades (Bansal et al. 2009; Kosmas et al. 2009 ). Most cases of clinical early-stage disease (stages IA1-IIA, according to the International Federation of Gynecology and Obstetrics) are treated and cured with either hysterectomy or primary radiotherapy. However, many cases are not diagnosed until later stages: approximately 35% at the time of regional metastases, and 10% have distant metastases. In spite of therapeutic measures such as neoadjuvant chemotherapy and radiotherapy, the overall recurrence rate within 1 year upon the completion of therapy is 50%, and 75-80% within 2 years in these patients. Local recurrence in the pelvic cavity accounts for 70%, and distant metastasis for the remaining 30%.
According to the cancer stem cell theory (Tu et al. 2002; Szotek et al. 2006; Al-Hajj et al. 2003) , cancer is a stem cell disease. Cancer stem cells have the potential for infinite proliferation, and play a crucial role in the initiation and progress of tumorigenesis. The remaining subpopulation in the tumor is fated for death through transient differentiation. In addition, some authors suggest that tumor stem cells are responsible for the recurrence and metastasis of tumors (Tu et al. 2002) . Identification and characterization of tumor stem cells would therefore provide a basis for the development of novel therapeutic strategies.
The isolation of cancer stem cells, also known as side population (SP) selection, is based on the recognition of their biological features (Szotek et al. 2006) . SP cells exhibit the capacity for almost unlimited self-renewal and proliferation in vitro and form tumors in vivo with an inoculation of very low cell numbers in mice. Thus the SP cell is regarded as a tumor stem cell (Tu et al. 2002) . In the absence of a specific surface marker for the related tumor stem cell, isolation using the DNA staining dye Hoechst 33342 is an important method of identification. However, Hoechst 33342 is not completely non-toxic. In cells which undergo the SP selection, particularly those of the non-SP phenotype, chronic accumulation of the staining dye results in an unpredictable influence on biological features and functions of the cells. Recently the expression of breast cancer-resistance protein (Bcrp1) has become a biological basis of isolation. It is independent of the use of Hoechst 33342, and therefore is an important method for the isolation of cancer stem cells.
Despite the isolation and characterization of cancer stem cells from a wide variety of other malignancies, there has been no report on cervical cancers or cell lines of cervical cancer. Such identification could lead to the improvement of our ability to develop novel preventive and therapeutic modalities for this disease.
With an improved methodology, we attempted to isolate and characterize SP cells from HeLa, a cell line derived from a patient with cervical cancer.
Materials and methods

Materials
The parent HeLa cell line was purchased from the Shanghai Cell Institute at the Chinese Academy of Science (Shanghai, China). Bcrp1 and the directlylabeled human BCRP1 antibody, Matrigel, and Transwells were bought from the BD Corporation (Franklin Lakes, NJ, USA). The fluorescent labeling reagents fluorescein isothiocyanate (FITC) and Cy3 were purchased from Sigma-Aldrich. The staining kit for immunohistology was obtained from Maixin Biotechnology (Fuzhou, China). The proliferation determination kit for propidium iodide (PI) labeling was purchased from Dingguo (Beijing, China). The standardized fetal bovine sera were obtained from Haoyang Biotechnology (Tianjin, China). Dulbecco's modified Eagle's medium (DMEM) with high glucose and trypsin was purchased from GIBCO (Burlington, Ontario, Canada). The 6-8 week-old non-obesity diabetes/severe combined immunodeficiency (NOD/ SCID) female mice were obtained from Fuzhong Biotechnology (Shanghai, China).
HeLa cell line culture
HeLa cells were maintained in DMEM supplemented with 10% fetal bovine serum (FBS). The doubling time was about 72 h and the nearly confluent cells (about 80%) were passaged at a ratio of 1:3.
Cell sorting with flow cytometry (FCM)
The nearly confluent cells were detached with 0.25% trypsin/0.02% ethylenediaminetetraacetic acid (EDTA) and 10 6 cells in 20 lL of PBS were incubated with phycoerythrin (PE)-labeled mouse anti-human BCRP1 monoclonal antibody for about 30 min in the dark. Then the Bcrp1-positive (Bcrp1 ? ) cells were collected and sorted by FCM (BD FACS Calibur, Franklin Lakes/NJ, USA).
Evaluation of cell proliferation
After FCM sorting, Bcrp1
? or Bcrp1 -cells were seeded onto 24 well plate at a density of 5 9 10 4 cells per well. Cells were incubated in 5% CO 2 at 37°C for indicated time period. For determination of cell growth ability, cells were digested by trypsin and subsequently stained with trypan blue, a living-cell exclusion dye. Each treatment was performed in triplicate. The average number of live cells was calculated and growth curve was drawn.
In vivo tumorigenesis in NOD/SCID mice
Bcrp1
? and Bcrp1 -HeLa cells (10 3 , 10 4 , 10 5 , or 10 6 cells), in 200 lL DMEM/F12 were inoculated subcutaneously into 6-8 week old female NOD/SCID mice (5 mice/group). Close observation was carried out for tumor formation and the tumor size. After 8-12 weeks, the mice were sacrificed and the tumor tissues were removed and weighed. The protocol regarding animal welfare assurance had been reviewed and approved by the institutional review board of Jiling University.
Boyden chamber invasion assay
According to the method described by Albini et al. (1987) , HeLa cell invasion into restructured basement membrane was examined with a Boyden chamber. The cell insert was placed in a 24-well plate. Matrigel was diluted with DMEM at a ratio of 1:3. The amount of 20 lL of diluted Matrigel was added to the insert every 10 min, and the total amount of Matrigel was 60 lL. The plate was incubated in 5% CO 2 at 37°C for 30 min. Then the Bcrp1 ? and Bcrp1 -cells were added to the upper compartment separately and 200 lL of NIH-3T3 conditioned medium was added to the lower compartment. The plate was incubated in 5% CO 2 at 37°C for 5 h (h). The amount of invasive cells and the depth of invasion were observed with a confocal scanning microscope (Olympus).
Statistical analysis
All experiments were performed in triplicate. Student's t test and the v 2 test were used where appropriate. The statistical analysis was performed with Statistical Product and Service Solutions (SPSS) 13.0 software.
Results
Morphology and proliferative characteristics of the cancer stem cell
The HeLa cell culture contained a small fraction of Bcrp1
? subpopulation. Upon repeated sorting with FCM, it was confirmed that the Bcrp1
? subpopulation accounted for about 7% of HeLa cells (Fig. 1a, b 
and c). Bcrp1
? and Bcrp1 -cells were inoculated in DMEM with 10% FBS and incubated for 4 days. The majority (nearly 72.8%) of the Bcrp1
? cells anchored to the bottom of the flask 24 h after incubation. Vigorous proliferative capability correlated with culture duration (Fig. 1d) . Meanwhile, the attachment of Bcrp1
-cells required at least 48 h. The proportion that attached was about 18.7% and the death rate was about 87.4%, 72 h after inoculation (Fig. 1e) . We next investigated the growth ability of Bcrp1
? and Bcrp1 -cells after sorting. As shown by Fig. 1f , the number of Bcrp1 ? cells was gradually increased with time. However, the number of Bcrp1
-cells was slightly elevated on the second day after seeding, but decreased thereafter. Barely any live Bcrp1 -cells were detected on Day 4 after seeding (Fig. 1f) .
In vivo tumorigenicity in SCID mice
The two groups of HeLa cells were inoculated subcutaneously into the NOD/SCID mice to observe their tumorigenic capability. No tumor formed in either group when 10 3 cells were transplanted. When 10 4 Bcrp1 ? cells were transplanted, tumors formed in about 60% of the NOD/SCID mice. Moreover, 12 weeks after inoculation, the tumor volume in the Bcrp1
? HeLa cell group was 1.3 9 1.3 9 1.1 cm 3 . However, at the same level of cells transplanted into the Bcrp1 -group, no tumor was formed even at 12 weeks after inoculation (Table 1) . When 10 5 or 10 6 cells were transplanted, the incidence was significantly higher and the size of tumors was much bigger in the Bcrp1 ? group than in the Bcrp1 -group (P \ 0.05 for transplantation with either 10 5 or 10 6 cells; Table 1 , Fig. 2 ).
Invasive capability
To explore the invasive capability of Bcrp1 ? and Bcrp1 -HeLa cells, Boyden chamber invasion assay was applied. As revealed by Fig. 3 , after 5 h incubation at 37°C, the amount of cells that invaded through the artificial basement membrane in the Bcrp1 ? group was significantly greater than that in the Bcrp1 -group (99 ± 11.2 per 10 5 cells vs. 57 ± 7.3 per 10 5 cells, P \ 0.05). These results indicated that the invasive capability of Bcrp1
? HeLa cells was higher than that of Bcrp1 -HeLa cells.
Discussion
Neoplastic cells exhibit marked heterogeneity with respect to proliferation and differentiation (Bonnet and Dick 1997; Reya et al. 2001 ). For example, rare stem cells within the leukemic population have extensive proliferation and self-renewal capacities that are not found in the majority of leukemic cells. Further researches on leukemic stem cells demonstrate that they are necessary and sufficient to maintain leukemia properties (Bonnet and Dick 1997; Lapidot et al. 1994) . In 2003, Al-Hajj et al. firstly reported the isolation and identification of the tumorigenic cells CD44 ? CD24 -/low in eight of nine patients. As few as 100 cells with this phenotype were able to form tumors in mice, whereas tens of thousands of cells with alternate phenotypes failed to form tumors (Al-Hajj et al. 2003) . In the same year, Singh et al. reported the successful isolation, using CD133 magnetic beads, of a cancer stem cell in human brain tumors (Singh et al. 2003) . Following this, in a wide array of solid malignancies such as pancreatic carcinoma, ovarian cancers, prostate cancer and cancer stem cells have been isolated successfully (Tu et al. 2002; Bapat et al. 2005; Olempska et al. 2007; Collins et al. 2005 ). Szotek et al. suggest that the inherent metastatic and heterogeneous nature of cancers may be due to their derivation from distinct stem cells (Szotek et al. 2006) .
In normal tissues, stem cells safeguard tissue homeostasis and guarantee tissue repair throughout life. The decision between self-renewal and differentiation is influenced by a specialized microenvironment called the stem cell niche (Mitsiadis et al. 2007 ). Stem cells in the niche always maintain quiescent status. Although there is no report of exploring the niche of cancer stem cells, we postulate that the localization of cancer stem cells in niches and protection from the damage of cytotoxic drugs could be one of the determinants for the ability of cancer to metastasize, recur and resist chemotherapy. On the other hand, cancer stem cells express higher levels of ATP-binding cassette (ABC) transporters, including ; in the Bcrp1 -group, it was 0.7 9 0.5 9 0.5 cm those encoded by the multidrug-resistant (MDR) gene 1, the MDR protein, and Bcrp1, which contribute to drug resistance in many cancers by pumping drugs out of the cell. Hence, cancer stem cells exhibit another distinct feature, a high drug efflux capacity (Hirschmann-Jax et al. 2004; Kondo et al. 2004) . In this study we explored, for the first time, the isolation and characterization of cancer stem cells using Bcrp1 expression. The results indicated that ? subpopulation should be regarded as cervical cancer stem cells or the major component of cervical cancer stem cells (Fig. 1) . A previous study revealed that the human monoblastoid U937 tumor cells have differentiation and retrodifferentiation characteristics (Hass et al. 1990 (Fig. 2, Table 1 ). Moreover, Lewis et al. indicated that the TPD50 (log10) (tumor producing dose in 50% of the animals) for HeLa cells was 4.9, which means that when injecting 10 4.9 cells into nude mice, 50% of them come down with tumor growth (Lewis et al. 2001 
Bcrp1
? cells led to 100% of the tumor generation in nude mice (Table 1) .
The in vitro Boyden assembled basement membrane invasion assay is widely used to investigate the ability of tumor cells to invade and metastasize. Using this assay, we observed that, compared to Bcrp1 -
HeLa cells, more cells in the Bcrp1
? HeLa cell group migrated through the basement membrane and presented with an enhanced invasion capacity. Invasion capacity is one of the important determinants for metastasis and prognosis, and one of the main features of tumor stem cells. The theory on tumor stem cells suggests that tumor stem cells could migrate to specific organs and lead to tumor metastasis. It is possible that the organ or tissue specificity of tumor metastasis is due to the relatively small number of tumor stem cells that contribute to the proliferation, metastasis, and invasion of the tumor, while the remaining majority of tumor cells lack the capacity for metastasis. In this study we observed an increased invasive capacity of Bcrp1
? cells. It can therefore be postulated that cervical cancer stem cells are contained in a subpopulation of cells. We speculate that within a population of Bcrp1
? HeLa cells there is a certain number of cervical cancer stem cells (Fig. 3) .
In the study reported here, we isolated the Bcrp1 cell from the HeLa cell line, a cell line which is used universally as an in vitro cervical cancer model. We identified the subpopulation of cells that had a more vigorous proliferative capacity and greater invasion ability in vitro, and increased tumorigenesis in NOD/ SCID mice. Collectively, our results indicate that the Bcrp1 ? subpopulation of HeLa putatively consists of cervical cancer stem cell. Targeting this cell subpopulation may contribute to a favorable prognosis in patients with relapsed and/or metastatic cervical cancer.
